iBio competitors

iBio's competitors include Lexicon Pharmaceuticals, Illumina, Spring Bank Pharmaceuticals and Arbutus Biopharma
Add company...
iBio
iBio is a technology platform that develops pharmaceutical product applications.
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals develops therapeutic products for diseases relating to immunology, metabolism, cardiology and ophthalmology.
Illumina
Illumina is a global company that develops innovative array-based solutions for DNA, RNA, and protein analysis.
Spring Bank Pharmaceuticals
Spring Bank is a clinical-stage biopharmaceutical company engaged in the discovery and development of a novel class of therapeutics using its proprietary small molecule nucleic acid hybrid, or SMNH, chemistry platform.
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Founding Date
Founding Date
2008
Founding Date
1995
Founding Date
1998
Founding Date
2002
Founding Date
1992
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Newark, US HQ
Locations
Spring, US HQ
Jersey, JE
Orlando, US
Chicago, US
The Woodlands, US
Boston, US
Indianapolis, US
see more
Locations
San Diego, US HQ
Scoresby, AU
São Paulo, BR
Victoria, CA
Shanghai, CN
Beijing, CN
Minato, JP
see more
Locations
Hopkinton, US HQ
Milford, US
Locations
Burnaby, CA HQ
Warminster, US
Employees
Employees
43
Employees
168
Employees
6,20013% increase
Employees
15
Employees
1222% increase
Valuation ($)
Valuation ($)
16.3 m
Valuation ($)
1.1 b
Valuation ($)
52.4 b
Valuation ($)
156.9 m
Valuation ($)
551.3 m
Facebook likes
Facebook likes
N/A
Facebook likes
N/A
Facebook likes
15.4 k
Facebook likes
5.3 k
Facebook likes
N/A
Twitter followers
Twitter followers
N/A
Twitter followers
108
Twitter followers
57 k
Twitter followers
1.2 k
Twitter followers
N/A

Financial

Revenue (est.)
Revenue (est.)
$444k (FY, 2018)
Revenue (est.)
$90.3m (FY, 2017)
Revenue (est.)
$2.4b (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
$10.7m (FY, 2017)
Cost of goods
Cost of goods
N/A
Cost of goods
$1.9m (FY, 2017)
Cost of goods
$731.9m (FY, 2017)
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
$88.4m (FY, 2017)
Gross profit
$1.7b (FY, 2017)
Gross profit
N/A
Gross profit
N/A
Net income
Net income
N/A
Net income
N/A
Net income
$428.1m (FY, 2017)
Net income
($17.4m) (FY, 2016)
Net income
($84.4m) (FY, 2017)

Funding

Total funding raised
Total funding raised
$ 9.3m
Total funding raised
$ 244.7m
Total funding raised
N/A
Total funding raised
$ 14.4m
Total funding raised
N/A
For sources of this data, please see the company profileDownload Excel

View company profiles

Lexicon Pharmaceuticals
HQ
Spring, US
Employees
168

Lexicon Pharmaceuticals develops therapeutic products for diseases relating to immunology, metabolism, cardiology and ophthalmology.

View company
Illumina
HQ
San Diego, US
Employees
6,200↑ 13% increase

Illumina is a global company that develops innovative array-based solutions for DNA, RNA, and protein analysis.

View company
Spring Bank Pharmaceuticals
HQ
Hopkinton, US
Employees
15

Spring Bank is a clinical-stage biopharmaceutical company engaged in the discovery and development of a novel class of therapeutics using its proprietary small molecule nucleic acid hybrid, or SMNH, chemistry platform.

View company
Arbutus Biopharma
HQ
Burnaby, CA
Employees
122↑ 2% increase

Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.

View company